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Mainzer-Saldino syndrome (MSS) is a rare disorder characterized by phalangeal cone-shaped epiphyses, chronic renal failure, and early-
onset, severe retinal dystrophy. Through a combination of ciliome resequencing and Sanger sequencing, we identified IFT140mutations
in sixMSS families and in a family with the clinically overlapping Jeune syndrome. IFT140 is one of the six currently known components
of the intraflagellar transport complex A (IFT-A) that regulates retrograde protein transport in ciliated cells. Ciliary abundance and local-
ization of anterograde IFTs were altered in fibroblasts of affected individuals, a result that supports the pivotal role of IFT140 in proper
development and function of ciliated cells.Ciliopathies are an emerging class of genetic disorders
caused by altered cilia assembly, maintenance, or func-
tion.1,2 They comprise a broad range of phenotypes that
result from developmental or functional defects of unique
or multiple systems. Syndromic ciliopathies that affect
bone development are classified as skeletal ciliopathies.1,2
Mutations in genes that encode components of the intra-
flagellar transport complex A (IFT-A), which drives
retrograde ciliary transport,3 are a major cause of skeletal
ciliopathies.4–11 Alterations of all IFT-A components but
one (IFT140) have been previously reported to cause Sense-
nbrenner, Jeune, and/or short-rib polydactyly syndromes
(IFT43 [MIM 614068], IFT122 [MIM 606045], IFT139
[MIM 612014], IFT144 [MIM 608151], WDR35 [MIM
613602]).4–11
Mainzer-Saldino syndrome (MSS [MIM 266920]), or con-
orenal syndrome (CRS), is a rare autosomal recessive
disease defined by phalangeal cone-shaped epiphyses
(PCSE), chronic renal disease, nearly constant retinal
dystrophy, andmild radiographic abnormality of the prox-
imal femur.12 Occasional features include short stature,
cerebellar ataxia, and hepatic fibrosis.12 MSS shares retinal
dystrophy with Leber congenital amaurosis (LCA [MIM
204000]) and nephronophthisis (NPHP [MIM 256100]),
and skeletal features with asphyxiating thoracic dystrophy
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syndrome, suggesting that it is a ciliopathy.
We collected 15 families presenting three diagnostic
criteria of MSS, namely early-onset retinal dystrophy,
PCSE, and renal disease, and two families with nonovert
renal disease (Tables S1 and S2). Informed consent was
obtained for each individual participating in this study,
which was approved by the Comite´ de Protection des Per-
sonnes ‘‘Ile-de-France II.’’ To identify the genetic mutations
responsible for MSS, we subjected the genomic DNA of an
affected individual born to unrelated parents (FI1; Figure 1
and Table S1) to ciliome resequencing, using a 5.3 Mb
customized Agilent SureSelect Target Enrichment library
to capture 32,146 exons of 1,666 genes. We first focused
our analysis on consensus splice-site changes, nonsynony-
mous variants, and insertion and/or deletion in coding
regions. Considering that MSS-causing mutations are
rare, we assumed that the affected individual was likely
compound heterozygous for variants absent in the
dbSNP132, 1000Genome, and in-house databases. This
pointed to one candidate gene only, IFT140 (intraflagellar
transport protein 140 homolog (chalydomonas);
[NM_014714.3]), which encodes the last IFT-A component
not yet shown to be related to skeletal ciliopathies (Table
S3). We found both a missense and a donor splice-site
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Figure 1. Clinical and Radiological Manifestations of MSS-Affected Individuals
(A and B) Photograph and thorax X-rays of affected individual FI1 at 17 years of age showing narrow chest.
(C–E) Hip X-rays of affected individuals FI1 (17 years), FIII1 (9 years), and FIII2 (5 years) showing flattened femoral epiphyses (C–D) and
wide femoral neck with areas of sclerosis in the metaphyseal region (arrows).
(F–J) Hand X-ray of affected individuals FI1, FIII1, FIII2, FII1, and FV1 showing PCSE (arrows).
(K–N) Renal biopsy from affected individual FVI1 at 2 years (periodic acid-Schiff [PAS] in K and L; trichrome staining in M and N)
showing severe tubulointerstitial lesions characterized by dedifferentiated and dilated tubules as well as atrophic tubules surrounded
by marked thickening of the tubular basement membrane (arrow) and interstitial fibrosis with infiltrates (asterisks). Scale bar: 100 mm.altered an acidic residue conserved across species
(c.1990G>A [p.Glu664Lys]), whereas we expected the
splice-site mutation to result in the skipping of exon 18
and/or the use of a surrounding cryptic splice site (c.2399þ
1G>T). Sanger sequencing confirmed these results, and
segregation analysis excluded allelism of the variants.
Additional ciliome resequencing and/or Sanger
sequencing of the 29 IFT140 coding exons (3 to 31, Table
S4) and intron-exon boundaries detected homozygous or
compound-heterozygous disease-causing mutations in
five other MSS families (Figures 1 and 2; Table 1, Tables
S1 and S3) and single heterozygote mutations in four
additional families (Table 1 and Table S2). All changes
were absent from 200 control chromosomes and were pre-
dicted to be deleterious with the use of the Alamut Muta-
tion Interpretation Software, a decision support system
for mutation interpretation based on Align DGVD,
Polyphen-2, SIFT, SpliceSiteFinder-like, MaxEntScan,
NNSPLICE and Human Splicing Finder (Table 1). Segrega-
tion of compound-heterozygous and homozygous muta-
tions with the disease was confirmed.
Affected individuals of the nonconsanguineous simplex
FII and multiplex FV families were compound heterozy-
gous for missense and truncating mutations, whereas
those of the multiplex consanguineous families III and
IV from Saudi Arabia were homozygous for missense muta-
tions (Table 1 and Figure 2). Affected cases of these latter
two families harbored the c.1990G>A (p.Glu664Lys)
change identified in affected individual FI1 (Table 1 and
Figure 2). Linkage analysis at the IFT140 locus detected
an intragenic IFT140 recombination, precluding the search
for linkage disequilibrium in families segregating this latter
change (Figure S1). Affected individuals FVIII1, FIX1, and
FX1 were single heterozygous for missense mutations.
FXI1 harbored a conservative change that we predictedThe Amwould create 4 bp upstream of the intron 5 donor splice
site, a competing donor site, the use of which would
result in the appearance of a premature stop codon
(c.489C>T [p.Gly163Gly and p.Glu164Thrfs*10]; Table 1
and Table S2).
The effect of the c.634G>A (p.Gly212Arg), c.699T>G
(p.Ile233Met), c.932A>G (p.Tyr311Cys), and c.1990G>A
(p.Glu664Lys) changes on the IFT140 localization was as-
sessed in the telomerase-immortalized retinal pigment
epithelial cell line (RPE1). Flag-tagged IFT140 mutant
proteins showed a partial to nearly complete loss of basal
body localization associated with an increase of cytoplasm
staining, whereas the wild-type Flag-tagged IFT140 protein
predominantly localized to the basal bodies in RPE1
cells (Figure 3A). The c.1990G>A (p.Glu664Lys) change
displayed the most severe disorganization (IFT140 misloc-
alization in 80% of the cells; Figure 3A).
To assess the impact of IFT140 mutations on ciliogene-
sis, abundance and morphology of primary cilia were
studied in cultured fibroblasts of affected individuals FII1
and FIV3. By staining the cilia axonemes with acetylated
alpha-tubulin, we detected absent cilia in a high propor-
tion of cells of affected cases compared to controls (mean
affected cases versus mean controls: 55.10% versus
83.61%, p < .0001), supporting a defect in ciliogenesis
and/or cilia maintenance (Figure 3B).
To determine the effect of the IFT140 mutations on
retrograde intraflagellar transport, we analyzed the endog-
enous subcellular localization of IFT140. The fibroblasts of
affected individuals FII1 (compound heterozygous for a
splice-site mutation and the c.932A>G [p.Tyr311Cys]
change) and FIV3 (homozygous for the c.1990G>A
[p.Glu664Lys] change) exhibited an unaltered IFT140
localization along the cilia axoneme (Figure 3C). However,
two components of the anterograde transport IFT-Berican Journal of Human Genetics 90, 864–870, May 4, 2012 865
Figure 2. IFT140 Organization, Protein Structure, and Mutations Identified in Homozygous and Compound-Heterozygous
Individuals Affected with Skeletal Ciliopathiescomplex, IFT88 and IFT46, were evenly distributed along
the cilium of both affected individual fibroblasts, whereas
they were predominantly detected at the base and the tip
of the cilium in control fibroblasts (p< 0.0001), suggesting
an alteration in retrograde ciliary transport (Figure 3C).Table 1. IFT140 Mutations Identified in Ten Individuals Affected with
Family Pedigree Diagnosis
Allele 1
Mutation Predicted Effe
FI simplex,
nonconsanguineous
MSS c.2399þ1G>T loss of intron 1
splice-site
FI simplex,
nonconsanguineous
MSS c.2399þ1G>T loss of intron 1
splice-site
FII simplex,
nonconsanguineous
MSS c.932A>G p.Tyr311Cys (d
FIII multiplex,
consanguineous
MSS c.1990G>A p.Glu664Lys (d
FIV multiplex,
consanguineous
MSS c.1990G>A p.Glu664Lys (d
FV multiplex,
nonconsanguineous
MSS c.634G>A p.Gly212Arg (d
and/or alteratio
6 donor-splice s
FVI simplex,
consanguineous
MSS c.699T>G p.Ile233Met (de
FVII simplex,
nonconsanguineous
Jeune
syndrome
c.2399þ1G>T loss of intron 1
splice-site
FVIII simplex,
nonconsanguineous
MSS c.1565G>A p.Gly522Glu (d
FIX simplex,
nonconsanguineous
MSS c.874G>A p.Val292Met (d
FX simplex,
nonconsanguineous
MSS c.1727G>A p.Arg576Gln (d
FXI simplex,
nonconsanguineous
MSS c.489C>T p.Gly163Gly an
donor splice sit
5 and predicted
(p.Glu164Thrfs
aVariant pathogenicity according to Align DGVD, Polyphen-2, SIFT, SpliceSiteFind
the Alamut Interpretation Software 2.0.
866 The American Journal of Human Genetics 90, 864–870, May 4, 2The defect in ciliogenesis and/or ciliary maintenance
and the aberrant distribution of IFT88 and IFT46 in cells
of affected individuals is consistent with the report of short
cilia and aberrant distribution of IFT88 in mutant reduced
mechanoreceptor potential A (rempA), the DrosophilaMainzer-Saldino Syndrome and a Child with Jeune Syndrome
Allele 2
cta Mutation Predicted Effecta
9 donor c.1990G>A p.Glu664Lys (deleterious)
9 donor c.1990G>A p.Glu664Lys (deleterious)
eleterious) c.857_860del p.Ile286Lysfs*6
eleterious) c.1990G>A p.Glu664Lys (deleterious)
eleterious) c.1990G>A p.Glu664Lys (deleterious)
eleterious)
n exon
ite
c.3916dup p.Ala1306Glyfs*56
leterious) c.699T>G p.Ile233Met (deleterious)
9 donor c.634G>A p.Gly212Arg (deleterious)
and/or alteration exon
6 donor splice site
eleterious) no mutation
identified
eleterious) no mutation
identified
eleterious) no mutation
identified
d creation of an additional
e 4 bp upstream of intron
to result in c.488_491del
*10)
no mutation
identified
er-like, MaxEntScan, NNSPLICE and Human Splicing Finder available through
012
ortholog of IFT140.13 The ternary IFT-B subcomplex, made
up of IFT52, IFT88, and IFT46, is crucial for the stabiliza-
tion of the IFT-B particle.14–16 Therefore, the data we
report further support the view that alterations of IFT-A
components disorganize assembly and/or maintenance
of ciliary structure by impairing retrograde IFT through
the redistribution of ciliary proteins (notably IFT-B com-
plex components).5,7,8,17,18
Genetic and clinical heterogeneity are hallmarks of
multisystemic ciliopathies.1,2 In addition, several exam-
ples have been reported which demonstrate that different
mutations in a same gene, e.g., WDR35,6,11 WDR19 [MIM
608151],8 CEP290 [MIM 610142],19 and IQCB1 [MIM
609237],20–22 can give rise to a broad range of phenotypes,
from isolated nephronophtisis or LCA to multisystemic
and sometimes embryonically lethal conditions. Geno-
type-phenotype correlations and global mutation load in
ciliary genes have been suggested to account for this clin-
ical variability.1,2 Here we report that IFT140 mutations
consistently caused PCSE as well as retinal dystrophy and
occasional chronic renal failure, hepatic fibrosis, addi-
tional skeletal abnormalities, or neurological symptoms.
Interestingly, although retinal dystrophy is an occasional
feature of skeletal ciliopathies,1,2 it is very uncommon in
patients with IFT-Amutations.5–8,10 Conversely, all affected
individuals with IFT140mutations and full ophthalmolog-
ical examination (n ¼ 9/10; six families) had LCA or early-
onset, severe retinal dystrophy between birth and 4 years
of age (Table S1). With regard to individual FVI1, who had
no reported retinal disease at the age of 2 years, electrophys-
iological recordings were not available to assess the func-
tion of photoreceptors, the alteration of which typically
precedes fundus changes. Retinal dystrophy appears there-
fore to be a very stringent clinical manifestation of IFT140
alterations. Although there is no clear-cut correlation
between tissue expression of IFTs and clinical features, the
recent report of the role of IFT140 in photoreceptor cell
ciliogenesis24 is consistent with the retinal disease of
MSS-affected individuals harboring IFT140mutations.
Chronic renal failure is an inclusion criterion in MSS.
However, age-at-onset and outcome of the dysfunction
vary, even within families.12 Therefore, it is possible that
renal failure occurs in affected individuals in families III
and IV (n ¼ 5, age range 4–17 years) late in the course of
the disease. This would be consistent with the recent
report of pronounced renal cystic disease in mice resulting
from HoxB7-Cre-driven loss of Ift140 in the renal collect-
ing duct.23 Nevertheless, affected individuals from families
III and IV were homozygous for a missense mutation
(c.1990G>A [p.Glu664Lys]), whereas all affected persons
with renal failure but one (FVI1) harbored a severe trun-
cating mutation (in addition to a missense mutation),
raising the question of whether some genotype-phenotype
correlations may exist. From this point of view, it is worth
noting that affected individual FVI1 harbored a homozy-
gous missense mutation (c.699T>G [p.Ile233Met]) and
heterozygous mutations in other ciliopathy genes,The AmTMEM67 (MIM 609884; data not shown) and XPNPEP3
(MIM 613553; Table S3B), which could contribute to
kidney failure.
Cerebral MRIs were consistently normal, but siblings
in two families exhibited neurological symptoms that
included mild intellectual impairment or autistic features,
seizures, and epilepsy (Families III and IV, respectively;
Table S1). Considering the high degree of consanguinity
of the two families, it is difficult to determine whether
some or all these traits are accounted for by IFT140
mutations, or if these disabilities are independently
inherited.
Some of the skeletal abnormalities of individuals with
IFT140mutations overlap with clinical symptoms of Jeune
and Sensenbrenner syndromes—namely, short hands, hip
and cranial abnormalities, narrow chest, and/or short
stature (Table S1). This overlap opens a debate as to
whether some affected individuals with IFT140 mutations
are affected with complex MSS, or incomplete Jeune or
Sensenbrenner syndromes (e.g., FI1, who had a narrow
chest but no respiratory deficiency and no trident acetab-
ular roof, or FVI1, who had trident acetabular roof,
a narrow chest, and short ribs; Table S1). Additionally,
this clinical overlap raises the question of whether other
skeletal ciliopathies are accounted for by IFT140 alter-
ations. So far the screening of large cohorts of individuals
affected with Sensenbrenner of Jeune syndromes failed to
detect IFT140 mutations.8 However, during this study, we
had the opportunity to identify IFT140 mutations in
a child affected with Jeune syndrome (FVII1, Table S1).
The child was compound heterozygous for a splice-site
mutation and the c.634G>A (p.Gly212Arg) change identi-
fied in Family V. These data suggest that mutations in
IFT140 may be a rare cause of Jeune syndrome and that
there is no clear correlation between the IFT140 genotype
and the severity of the disease.
The clinical presentation of the disease did not differ
significantly in MSS-affected individuals with two IFT140
disease alleles compared to single-heterozygous patients
(4/17) or affected individuals with no mutation (7/18;
Tables S1 and S2). It is possible that some of the latter
10/17 affected individuals may harbor undetected IFT140
mutations lying in unscreened regions, such as untrans-
lated regions or introns. Furthermore, following the
example of the deep intronic CEP290 c.1991þ1655A>G
mutation, which accounts for approximately 60% of
CEP290 disease alleles in LCA, it is possible that a common
undetected IFT140 mutation may exist.19 However, like
most other ciliopathies, MSS may be genetically heteroge-
neouswith someor all 10/17 affected individuals, including
single heterozygotes, harboring mutations in other genes.
In summary, we here report on compound heterozy-
gosity or homozygosity for IFT140 mutations in six
families affected with MSS and an individual affected
with Jeune syndrome. After Sensenbrenner and Jeune
syndromes, MSS is the latest skeletal ciliopathy ascribed
to IFT disorganization.erican Journal of Human Genetics 90, 864–870, May 4, 2012 867
Figure 3. Distribution of Wild-Type and Mutant Endogenous or Flag-Tagged IFT140 in Fibroblasts and RPE1 Cells
(A) Aberrant distribution of Flag-tagged mutant IFT140 proteins in RPE1 cells. Cells were transfected with pCMV-IFT140-WT-Flag,
pCMV-IFT140-Glu212Arg-Flag, pCMV-IFT140-Ile233Met-Flag, pCMV-IFT140-Tyr311Cys-Flag, and pCMV-IFT140-Glu664Lys-Flag
plasmids, respectively. Flag-tagged proteins were stained with the use of rabbit anti-Flag (1:200, Sigma-Aldrich) and Alexa Fluor
555-conjugated anti-rabbit (1:200, Molecular Probes; red) primary and secondary antibodies, respectively. Basal bodies were stained
with the use ofmousemonoclonal anti-g-tubulin (1:1000, Sigma-Aldrich) and Alexa Fluor 488-conjugated anti-mouse (1:200, Molecular
Probes) primary and secondary antibodies, respectively. Images were recorded with a Leica SP5 confocal microsocope (Leica). Scale
bars 5 mm. Wild-type (WT) IFT140 is clearly visible at the basal body (white arrow), whereas mutant proteins exhibit a significant
cytoplasmic staining with decreased basal body labeling. The graph shows the percentage of transfected cells with localization of the
Flag-tagged IFT140 protein at the basal body calculated from two independent experiments, and n > 100 cells for each transfection
condition (***: p < 0.001 calculated via Dunn’s Multiple Comparison Test following the analysis of variance [ANOVA] test, GraphPad
Prism Software).
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